Chlamydia pneumoniae immunoreactivity in coronary artery plaques of patients with acute coronary syndromes and its relation with serology

American Heart Journal

Volumn 150, Issue 4, 2005, Pages 681-688

  Liu, Ruiqin ^a   Yamamoto, Masato ^a   Moroi, Masao ^a   Kubota, Tetsuya ^a   Ono, Tsuyoshi ^a   Funatsu, Atsushi ^a   Komatsu, Hiroki ^a   Tsuji, Takahiro ^a   Hara, Hidehiko ^a   Hara, Hisao ^a   Nakamura, Masato ^a   Hirai, Hironori ^a   Yamaguchi, Tetsu ^b  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; ATHERECTOMY; ATHEROSCLEROSIS; CELL DENSITY; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; MALE; MEASUREMENT; PATIENT; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SEROLOGY; THROMBECTOMY;

ACUTE DISEASE; AGED; ANGINA, UNSTABLE; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SEROLOGIC TESTS; SYNDROME;

EID: 25844491781     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.11.028     Document Type: Article

References (55)

1. P. Saikku, K. Mattila, and M.S. Nieminen Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction Lancet 2 1988 983 986
2. D.H. Thom, J.T. Grayston, and D.S. Siscovick Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease JAMA 268 1992 68 72
3. J.T. Grayston Background and current knowledge of Chlamydia pneumoniae and atherosclerosis J Infect Dis 181 2000 402 410
4. M.A. Mendall, D. Carrington, and D.P. Strachan Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease J Infect 30 1995 121 128
5. G.H. Dahlen, J. Boman, and L.S. Birgander Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease Atherosclerosis 114 1995 165 174
6. A. Shor, C.C. Kuo, and D.L. Patton Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques S Afr Med J 82 1992 158 161
7. A. Vink, G. Pasterkamp, and M. Poppen The adventitia of atherosclerotic coronary arteries frequently contains Chlamydia pneumoniae Atherosclerosis 157 2001 117 122
8. M. Maass, J. Jahn, and J. Gieffers Detection of Chlamydia pneumoniae with peripheral blood monocytes of patients with unstable angina or myocardial infection J Infect Dis 181 2000 449 4451
9. K. Ericson, T.G. Saldeen, and O. Lindquist Relationship of Chlamydia pneumoniae to severity of human coronary atherosclerosis Circulation 101 2000 2568 2571
10. Y. Wong, M. Thomas, and V. Tsang The prevalence of Chlamydia pneumoniae in atherosclerotic and non-atherosclerotic blood vessels of patients attending for redo and first time coronary artery bypass graft surgery J Am Coll Cardiol 33 1999 152 156
11. J.A. Ramirez Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis: the Chlamydia pneumoniae/ Atherosclerosis Study Group Ann Intern Med 125 1996 979 982
12. P. Apfalter, M. Loidl, and R. Nadrchal Isolation and continuous growth of Chlamydia pneumoniae from atherectomy specimens Eur J Clin Microbiol Infect Dis 19 2000 305 308
13. H. He, G.N. Prerce, and G. Zhong The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae J Clin Invest 103 1999 747 753
14. J.B. Muhlestein, J.L. Anderson, and E.H. Hammond Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model Circulation 97 1998 633 636
15. J.J. Boyle Association of coronary plaque rupture and atherosclerotic inflammation J Path 181 1997 93 99
16. M.L. Higuchi, H.G. Bezerra, and S. Palomino Adventitial fibrosis and inflammation surrounding atheroma: implications for different arterial remodeling in stable and unstable plaques J Am Coll Cardiol 35 2000 3684
17. P. Libby, Y.J. Geng, and M. Aikawa Macrophages and atherosclerotic plaque stability Curr Opin Lipidol 7 1996 330 335
18. J. Danesh, and R. Collons Chronic infections and coronary heart disease: is there a link? Lancet 350 1997 430 436
19. J. Danesh, P. Whincup, and M. Walker Chlamydia pneumoniae IgG titers and coronary heart disease: prospective study and meta-analysis BMJ 321 2000 208 213
20. J. Danesh, P. Whincup, and S. Lewington Chlamydia pneumoniae IgA titers and coronary heart disease: prospective study and meta-analysis Eur Heart J 23 2002 371 375
21. K. Shimada, H. Mokuno, and Y. Watanabe High prevalence of seropositivity for antibodies to chlamydia-specific lipopolysaccharide in patients with acute coronary syndrome J Cardiovasc Risk 7 2000 209 213
22. B.Y. Wong, J. Gnarpe, and K.K. Teo Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes Am Heart J 144 2002 987 994
23. J. Gnarpe, A. Sparr, and J. Naas Serological analysis of specific IgA to Chlamydia pneumoniae: increased sensitivity of IgA antibody detection using prolonged incubation and high antigen concentration APMIS 108 2000 357 362
24. M.L. Higuchi, J.B. Castelli, and V.D. Aiello Great amount of C. pneumoniae in ruptured plaque vessel segments at autopsy. A comparative study with stable plaque Arq Bras Cardiol 74 2000 149 151
25. M. Puolakkainen, J. Parker, and C.C. Kuo Further characterization of Chlamydia pneumoniae specific monoclonal antibodies Microbiol Immunol 39 1995 551 554
26. M. Mass, C. Bartels, and P.M. Engel Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease J Am Coll Cardiol 31 1998 827 832
27. L.A. Jackson, L.A. Campbell, and R.A. Schmidt Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma-evaluation of the innocent bystander hypothesis Am J Pathol 150 1997 1785 1790
28. V. Murat, M.V. Kalayoglu, and P. Libby Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease JAMA 288 2002 2731 2734
29. Y. Wong, M. Thomas, and V. Tsang The prevalence of Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic blood vessels of patients attending for redo and first time coronary artery bypass graft surgery J Am Coll Cardiol 33 1999 152 156
30. M. Thomas, Y. Wong, and D. Thomas Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (starry grading) of associated atherosclerotic plaque Circulation 99 1999 2733 2736
31. A. Vink, M. Poppen, and A.H. Schoneveld Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual Circulation 103 2001 1613 1617
32. W. Beatty, R. Morrison, and G. Byme Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis Microbiol Rev 58 1994 686 689
33. L.A. Campbell, E.R. O'Brien, and A.L. Cappuccio Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues J Infect Dis 172 1995 585 588
34. G. Ong, B.J. Thomas, and O.A. Manfield Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications J Clin Pathol 49 1996 102 106
35. G.I. Byrne, and M.V. Kalayoglu Chlamydia pneumoniae and atherosclerosis: links to the disease process Am Heart J 138 1999 488 490
36. P. Saikku, M. Leinonen, and L. Tenkanen Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study Ann Intern Med 116 1992 273 278
37. H. Miettinen, S. Lehto, and P. Saikku Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin-dependent diabetic and non-diabetic subjects in Finland Eur Heart J 17 1996 682 688
38. D.P. Strachan, D. Carrington, and M.A. Mendall Relation of Chlamydia pneumoniae serology to mortality and incidence of ischemic heart disease over 13 years in the Caerphilly Prospective Heart Disease Study BMJ 318 1999 1035 1039
39. N. Rifai, and P.M. Ridker High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease Clin Chem 47 2001 403 411
40. I. Abdelmouttaleb, N. Danchin, and C. Ilardo C-reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes Am Heart J 137 1999 346 351
41. S.S. Kaukoranta-Tolvanen, K. Laitinen, and P. Saikku Chlamydia pneumoniae multiplies in human endothelial cells in vitro Microb Pathol 26 1994 313 319
42. C.A. Gaydos, J.T. Summersgill, and N.N. Sahney Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells Infect Immun 64 1996 1614 1620
43. K.L. Godzik, E.R. O'Brien, and S.K. Wang In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae J Clin Microbiol 33 1995 2411 2414
44. E. Knoebel, P. Vijayagopal, and J.E. Figueroa In vitro infection of smooth muscle cells by Chlamydia pneumoniae Infect Immun 65 1997 503 506
45. S.S. Kaukoranta-Tolvanen, T. Ronnl, and M. Leinonen Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae Microbiol Pathol 21 1996 407 411
46. M.G. Netea, C.H. Selzman, and B.J. Kullberg Cellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells Eur J Immunol 30 2000 541 549
47. Y. Geng, R.B. Shane, and K. Berencst Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10 J Immunol 164 2000 5222 5229
48. L.M. Biasucci, G. Liuzzo, and A. Ciervo Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes Circulation 107 2003 3015 3017
49. M. Mayer, B. Metzler, and S. Kiechl Endothelial cytotoxicity mediated by serum antibodies to heat shock protein of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock protein as a possible link between infections and atherosclerosis Circulation 99 1999 1560 1566
50. A. Kol, T. Bourcier, and A.H. Lichtman Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages J Clin Invest 103 1999 571 577
51. A. Kol, G.K. Sulchova, and A.H. lichtman Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression Circulation 98 1998 300 307
52. P. Kreula, M. Puolakkainen, and M. Sarvas Chlamydia pneumoniae proteins induce secretion of the 92-kDa gelatinase by human monocyte derived macrophage Arterioscler Thromb Vasc Biol 21 2001 E1 E8
53. B. Cercek, P.K. Shah, and M. Noc Effect of short-term treatment with azithromycin on recurrent ischemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised control trial Lancet 361 2003 809 813
54. J.B. Muhlestein, J.L. Anderson, and J.F. Carlquist Randomized secondary prevention trial of azithromycin in patients with coronary artery disease. Primary clinical results of the ACADEMIC study Circulation 102 2000 1755 1760
55. C.M. O'Connor, M.W. Dunne, and M.A. Pfeffer Azithromycin for the secondary prevention of coronary heart disease events. The WIZARD study: a randomized control trial JAMA 290 2003 1459 1466